Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
Mestinon 60 mg Tablets.
| Pharmaceutical Form |
|---|
|
Tablet for oral administration. White to off-white, round, biplanar, bevel-edged tablets imprinted with “V/M60” across one face and with two break marks forming a cross on the other. |
Each tablet contains 60 mg pyridostigmine bromide.
For the full list of excipients, see section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Pyridostigmine |
Pyridostigmine is an antagonist to cholinesterase, the enzyme which normally destroys acetylcholine. The action of pyridostigmine can briefly be described, therefore, as the potentiation of naturally occurring acetylcholine. |
| List of Excipients |
|---|
|
Each tablet contains: Lactose |
Amber glass bottles with aluminium screw or low density polyethylene caps and desiccant containing 200 tablets.
Mylan Products Ltd, Station Close, Potters Bar, Hertfordshire, EN6 1TL, United Kingdom
PL 46302/0133
1 March 1998
| Drug | Countries | |
|---|---|---|
| MESTINON | Austria, Australia, Brazil, Canada, Ecuador, Estonia, Spain, Finland, France, Hong Kong, Croatia, Ireland, Israel, Japan, Lithuania, Malta, Mexico, Netherlands, New Zealand, Poland, Romania, Singapore, Turkey, United Kingdom, United States, South Africa |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
